TY - JOUR
T1 - The role for ketogenic diets in epilepsy and status epilepticus in adults
AU - Williams, Tanya J.
AU - Cervenka, Mackenzie C.
N1 - Funding Information:
The authors declare no conflicts of interest. Dr. Cervenka receives grants from Nutricia, Vitaflo, BrightFocus Foundation, and Army Research Laboratory as well as Honoraria from the American Epilepsy Society, New York University, The Neurology Center, and LivaNova.
Publisher Copyright:
© 2017
PY - 2017
Y1 - 2017
N2 - Ketogenic diet (KD) therapies are high fat, low carbohydrate diets designed to mimic a fasting state. Although studies demonstrate KD's success in reducing seizures stretching back nearly a century, the last 25 years have seen a resurgence in diet therapy for the management of drug-resistant epilepsy in children as well as adults. With ≥50% seizure reduction efficacy rates in adults of 22–55% for the classic KD and 12–67% for the modified Atkins diet, diet therapy may be in many instances comparable to a trial of an additional anti-epileptic medication and potentially with fewer side effects and other health benefits. Moreover, ketogenic diets offer promising new adjunctive strategies for the treatment of acute status epilepticus in the intensive care setting. Here, we review the efficacy and utility of ketogenic diets for the management of chronic epilepsy and refractory status epilepticus in adults and offer practical guidelines for diet implementation and maintenance.
AB - Ketogenic diet (KD) therapies are high fat, low carbohydrate diets designed to mimic a fasting state. Although studies demonstrate KD's success in reducing seizures stretching back nearly a century, the last 25 years have seen a resurgence in diet therapy for the management of drug-resistant epilepsy in children as well as adults. With ≥50% seizure reduction efficacy rates in adults of 22–55% for the classic KD and 12–67% for the modified Atkins diet, diet therapy may be in many instances comparable to a trial of an additional anti-epileptic medication and potentially with fewer side effects and other health benefits. Moreover, ketogenic diets offer promising new adjunctive strategies for the treatment of acute status epilepticus in the intensive care setting. Here, we review the efficacy and utility of ketogenic diets for the management of chronic epilepsy and refractory status epilepticus in adults and offer practical guidelines for diet implementation and maintenance.
KW - Drug-resistant epilepsy
KW - Epilepsy
KW - Ketogenic diet
KW - Modified Atkins diet
KW - Refractory status epilepticus
UR - http://www.scopus.com/inward/record.url?scp=85044627637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044627637&partnerID=8YFLogxK
U2 - 10.1016/j.cnp.2017.06.001
DO - 10.1016/j.cnp.2017.06.001
M3 - Review article
AN - SCOPUS:85044627637
SN - 2467-981X
VL - 2
SP - 154
EP - 160
JO - Clinical Neurophysiology Practice
JF - Clinical Neurophysiology Practice
ER -